EPISODE #120 Cannabinoid Hyperemesis Syndrome with Dr. Ethan Russo, Founder of Credo Science

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email



What is Cannabinoid Hyperemesis Syndrome (CHS)?

This week, we welcome back Dr. Ethan Russo, physician, researcher, and leading expert in the field of Medicinal Cannabis. 

In this episode, Dr Russo shares the latest research and findings of the largest study on CHS to date – in which his team identified 6 potential genetic targets to assist in the diagnosis and treatment of the condition.

→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e120

About Dr. Ethan Russo

Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Founder/CEO of CReDO Science https://credo-science.com 

Previously he was Director of Research and Development for the International Cannabis and Cannabinoids Institute, 2017-19, Medical Director of PHYTECS, 2015-2017, and from 2003-2014, Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®.

He was a clinical neurologist in Missoula, Montana for 20 years. He has held faculty appointments in Pharmaceutical Sciences at the University of Montana, and in Medicine at the University of Washington. He is author/editor of seven books and has published more than 50 peer-reviewed articles.

View original source video by clicking here

On Key

Related Posts

Charles Urquhart, . Psychedelics & Cannabinoid Therapeutics: What Does the Future Hold?

Watch the full version of this talk: https://www.conferencecast.tv/talk-33555-psychedelics-cannabinoid-therapeutics-what-does-the-future-hold?utm_campaign=33555&utm_source=youtube&utm_content=talk CBD Expo SOUTH 2020, December 11 – 12, 2020, Houston See more about the event: https://www.conferencecast.tv/event-1649-cbd-expo-south-2020?utm_campaign=33555&utm_source=youtube&utm_content=conf Psychedelics